The most recent earnings report from Cencora, Inc. (NYSE:COR) was disappointing for shareholders. While the headline numbers were soft, we believe that investors might be missing some encouraging ...

CONSHOHOCKEN, Pa., May 28, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1 ...

CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions provider with a market capitalization of $56.87 billion, announced the appointment of Lori J. Ryerkerk to its Board ...

Shares of Cencora Inc. COR shed 1.43% to $289.19 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.56% to 5,888.55 and ...

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

Russian-born tennis star Daria Kasatkina says she “didn’t have much choice” but to switch allegiances to Australia… China fires warning at US treaty ally Colorado Passes Law to Officially ...

Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025. “Ms. Ryerkerk’s experience in complex ...

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company. With a market cap of approximately $54 billion, Cencora operates through the U.S ...

In its first-quarter 2025 investor letter, TimesSquare Capital U.S. Focus Growth Strategy highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products ...

CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions provider with a market capitalization of $56.87 billion, announced the appointment of Lori J. Ryerkerk to its Board of ...